BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16189019)

  • 1. Kaposi's sarcoma-associated herpesvirus virion-induced transcription activation of the ORF50 immediate-early promoter.
    Lu F; Day L; Lieberman PM
    J Virol; 2005 Oct; 79(20):13180-5. PubMed ID: 16189019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency.
    Lu F; Zhou J; Wiedmer A; Madden K; Yuan Y; Lieberman PM
    J Virol; 2003 Nov; 77(21):11425-35. PubMed ID: 14557628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Sp1 response element in the Kaposi's sarcoma-associated herpesvirus open reading frame 50 promoter mediates lytic cycle induction by butyrate.
    Ye J; Shedd D; Miller G
    J Virol; 2005 Feb; 79(3):1397-408. PubMed ID: 15650166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct interactions of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50/Rta protein with the cellular protein octamer-1 and DNA are critical for specifying transactivation of a delayed-early promoter and stimulating viral reactivation.
    Carroll KD; Khadim F; Spadavecchia S; Palmeri D; Lukac DM
    J Virol; 2007 Aug; 81(16):8451-67. PubMed ID: 17537858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sp3 Transcription Factor Cooperates with the Kaposi's Sarcoma-Associated Herpesvirus ORF50 Protein To Synergistically Activate Specific Viral and Cellular Gene Promoters.
    Chen LY; Chen LW; Peng KT; Hung CH; Chang PJ; Wang SS
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the cellular transcription factor YY1 in the latent-lytic switch of Kaposi's sarcoma-associated herpesvirus.
    Chang PJ; Chen LW; Shih YC; Tsai PH; Liu AC; Hung CH; Liou JY; Wang SS
    Virology; 2011 May; 413(2):194-204. PubMed ID: 21376359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X box binding protein XBP-1s transactivates the Kaposi's sarcoma-associated herpesvirus (KSHV) ORF50 promoter, linking plasma cell differentiation to KSHV reactivation from latency.
    Wilson SJ; Tsao EH; Webb BL; Ye H; Dalton-Griffin L; Tsantoulas C; Gale CV; Du MQ; Whitehouse A; Kellam P
    J Virol; 2007 Dec; 81(24):13578-86. PubMed ID: 17928342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kaposi's Sarcoma-Associated Herpesvirus Reactivation by Targeting of a dCas9-Based Transcription Activator to the ORF50 Promoter.
    Elbasani E; Falasco F; Gramolelli S; Nurminen V; Günther T; Weltner J; Balboa D; Grundhoff A; Otonkoski T; Ojala PM
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32867368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the NEDD8-Activating Enzyme Inhibitor MLN4924 on Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus.
    Chang PJ; Chen LW; Chen LY; Hung CH; Shih YJ; Wang SS
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
    Ye J; Gradoville L; Daigle D; Miller G
    J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoregulation of DNA binding and protein stability of Kaposi's sarcoma-associated herpesvirus ORF50 protein.
    Chang PJ; Miller G
    J Virol; 2004 Oct; 78(19):10657-73. PubMed ID: 15367633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression from the ORF50/K8 region of Kaposi's sarcoma-associated herpesvirus.
    Seaman WT; Ye D; Wang RX; Hale EE; Weisse M; Quinlivan EB
    Virology; 1999 Oct; 263(2):436-49. PubMed ID: 10544116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ORF50-dependent and ORF50-independent activation of the ORF45 gene of Kaposi's sarcoma-associated herpesvirus.
    Chang PJ; Wang SS; Chen LY; Hung CH; Huang HY; Shih YJ; Yen JB; Liou JY; Chen LW
    Virology; 2013 Jul; 442(1):38-50. PubMed ID: 23601787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency.
    Lan K; Kuppers DA; Verma SC; Sharma N; Murakami M; Robertson ES
    J Virol; 2005 Jun; 79(12):7453-65. PubMed ID: 15919901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of regulation of RTA-responsive genes in Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8.
    Song MJ; Deng H; Sun R
    J Virol; 2003 Sep; 77(17):9451-62. PubMed ID: 12915560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Octamer-binding sequence is a key element for the autoregulation of Kaposi's sarcoma-associated herpesvirus ORF50/Lyta gene expression.
    Sakakibara S; Ueda K; Chen J; Okuno T; Yamanishi K
    J Virol; 2001 Aug; 75(15):6894-900. PubMed ID: 11435569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA binding by Kaposi's sarcoma-associated herpesvirus lytic switch protein is necessary for transcriptional activation of two viral delayed early promoters.
    Lukac DM; Garibyan L; Kirshner JR; Palmeri D; Ganem D
    J Virol; 2001 Aug; 75(15):6786-99. PubMed ID: 11435557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cohesins repress Kaposi's sarcoma-associated herpesvirus immediate early gene transcription during latency.
    Chen HS; Wikramasinghe P; Showe L; Lieberman PM
    J Virol; 2012 Sep; 86(17):9454-64. PubMed ID: 22740398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide identification of binding sites for Kaposi's sarcoma-associated herpesvirus lytic switch protein, RTA.
    Chen J; Ye F; Xie J; Kuhne K; Gao SJ
    Virology; 2009 Apr; 386(2):290-302. PubMed ID: 19233445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KSHV PAN RNA associates with demethylases UTX and JMJD3 to activate lytic replication through a physical interaction with the virus genome.
    Rossetto CC; Pari G
    PLoS Pathog; 2012; 8(5):e1002680. PubMed ID: 22589717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.